首站-论文投稿智能助手
典型文献
First report of polymicrobial necrotizing fasciitis caused by Eggerthia catenaformis and Finegoldia magna
文献摘要:
Dear editor, Necrotizing fasciitis is a relatively rare, rapidly advancing, infectious disease with high lethality.[1] It is characterized by subcutaneous and fascial tissue necrosis and can even extend to involve skin and muscle.[2] The initial spread along fascial planes with little visual evidence impedes the crucial early diagnosis. Patients often report minor or major trauma preceding the infection, yet in some cases, the disease develops idiopathically.[3] Risk factors, including older age, diabetes, chronic renal failure, and obesity, predispose to impaired immunity and loss of physiological barriers.
文献关键词:
作者姓名:
Claudius Illg;Jonas Kolbenschlag;Ruth Christine Sch?fer;Adrien Daigeler;Sabrina Krauss
作者机构:
Department of Hand,Plastic and Reconstructive Surgery,BG Unfallklinik Tuebingen,Eberhard Karls University,Tuebingen 72076,Germany
引用格式:
[1]Claudius Illg;Jonas Kolbenschlag;Ruth Christine Sch?fer;Adrien Daigeler;Sabrina Krauss-.First report of polymicrobial necrotizing fasciitis caused by Eggerthia catenaformis and Finegoldia magna)[J].世界急诊医学杂志(英文),2022(04):326-329
A类:
Eggerthia,catenaformis,Finegoldia, Necrotizing,idiopathically,predispose
B类:
First,report,polymicrobial,necrotizing,fasciitis,caused,by,magna,Dear,editor,relatively,rare,rapidly,advancing,infectious,disease,high,lethality,It,characterized,subcutaneous,fascial,tissue,necrosis,can,even,extend,involve,skin,muscle,initial,spread,along,planes,little,visual,evidence,impedes,crucial,early,diagnosis,Patients,often,minor,major,trauma,preceding,infection,yet,some,cases,develops,Risk,factors,including,older,age,diabetes,chronic,renal,failure,obesity,impaired,immunity,loss,physiological,barriers
AB值:
0.715851
相似文献
Knowledge about,attitude and acceptance towards,and predictors of intention to receive the COVID-19 vaccine among cancer patients in Eastern China:A cross-sectional survey
Jing Hong;Xiao-wan Xu;Jing Yang;Jing Zheng;Shu-mei Dai;Ju Zhou;Qing-mei Zhang;Yi Ruan;Chang-quan Ling-School of Traditional Chinese Medicine,Naval Medical University,Shanghai 200433,China;Department of Integrative Oncology,Changhai Hospital,Naval Medical University,Shanghai 200433,China;Department of Oncology,The First Affiliated Hospital,Bengbu Medical College,Bengbu 233010,Anhui Province,China;Department of Nursing,Fuyang Cancer Hospital,Fuyang 236000,Anhui Province,China;Department of Cardiac Rehabilitation,Shanghai First Rehabilitation Hospital,Shanghai 200090,China;Department of Radiation Oncology,Anhui Chest Hospital,Hefei 230022,Anhui Province,China;Department of Anesthesiology,Chaohu Hospital,Anhui Medical University,Hefei 238000,Anhui Province,China
Multimorbidity patterns and association with mortality in 0.5 million Chinese adults
Fan Junning;Sun Zhijia;Yu Canqing;Guo Yu;Pei Pei;Yang Ling;Chen Yiping;Du Huaidong;Sun Dianjianyi;Pang Yuanjie;Zhang Jun;Gilbert Simon;Avery Daniel;Chen Junshi;Chen Zhengming;Lyu Jun;Li Liming-Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing 100191, China;Peking University Center for Public Health and Epidemic Preparedness and Response, Peking University, Beijing 100191, China;National Clinical Research Center of Cardiovascular Diseases, National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China;China Kadoorie Biobank National Coordination Centre, Chinese Academy of Medical Sciences, Beijing 100730, China;Nuffield Department of Population Health, Medical Research Council Population Health Research Unit, University of Oxford, Oxford OX3 7LF, United Kingdom;Nuffield Department of Population Health, University of Oxford, Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU), Oxford OX3 7LF, United Kingdom;Suzhou Center for Disease Control and Prevention, Suzhou, Jiangsu 215004, China;China National Center for Food Safety Risk Assessment, Beijing 100022, China;Key Laboratory of Molecular Cardiovascular Sciences, Peking University, Ministry of Education, Beijing 100191, China
Early assessment of the safety and immunogenicity of a third dose(booster)of COVID-19 immunization in Chinese adults
Yuntao Zhang;Yunkai Yang;Niu Qiao;Xuewei Wang;Ling Ding;Xiujuan Zhu;Yu Liang;Zibo Han;Feng Liu;Xinxin Zhang;Xiaoming Yang-China National Biotec Group Company Limited,Beijing 100024,China;Shanghai Institute of Hematology,State Key Laboratory of Medical Genomics,National Research Center for Translational Medicine at Shanghai,Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine,Shanghai 200025,China;Beijing Institute of Biological Products,China National Biotec Group Company Limited,Beijing 100176,China;National Vaccine and Serum Institute,China National Biotec Group Company Limited,Beijing 101111,China;Department of Infectious Diseases,Research Laboratory of Clinical Virology,Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine,Shanghai 200025,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。